机译:丹麦肝素的成本效果与未分叉的肝素用于预防危重病人的静脉血栓栓塞
Sunnybrook Health Sciences Centre University of Toronto 2075 Bayview AveToronto ON Canada;
Health Outcomes and PharmacoEconomic Canada;
Research Centre Sunnybrook Health Sciences CentreToronto ON Canada;
Department of Pharmacology University of TorontoToronto ON Canada Department of Anesthesiology;
Department of Medicine University of TorontoToronto ON Canada;
Department of Clinical Epidemiology and Biostatistics McMaster UniversityHamilton ON Canada;
Department of Research and Evaluation Kaiser Permanente Southern CaliforniaPasadena CA United;
George Institute for Global Health Royal North Shore Hospital University of SydneySt Leonards;
Institute of Health Policy Management and Evaluation University of TorontoToronto ON Canada;
Toronto Health Economics and Technology Assessment Canada;
Collaborative University of TorontoToronto ON Canada;
King Saud Bin Abdulaziz University for Health Sciences and King Abdullah International Medical;
Department of Medicine King Faisal Specialist Hospital and Research Centre-GenJeddah Saudi Arabia;
Department of Intensive Care Hospitalar Santa CasaPorto Alegre Brazil;
Center for Health Evaluation and Outcome Sciences Division of Critical Care Medicine St Paul's;
Ottawa Hospital Research Institute Centre for Transfusion and Critical Care Research Department;
Ottawa HospitalOttawa ON Canada Critical Care Medicine Hital Maisonneuve-RosemontMontreal QC;
Department of Anesthesiology Dalhousie University Capital District Health AuthorityHalifax NS;
Department of Medicine Dalhousie University Capital District Health AuthorityHalifax NS Canada;
Department of Pharmacology Dalhousie University Capital District Health AuthorityHalifax NS;
Department of Surgery Dalhousie University Capital District Health AuthorityHalifax NS Canada;
Interdepartmental Division of Critical Care Medicine Department of Medicine University of;
Interdepartmental Division of Critical Care Medicine Department of Physiology University of;
Division of Respirology Department of Medicine University Health NetworkToronto ON Canada;
Mount Sinai HospitalToronto ON Canada Department of Medicine McMaster UniversityHamilton ON;
Department of Surgery University of TorontoToronto ON Canada;
Keenan Research Centre Li Ka Shing Knowledge Institute StMichael's HospitalToronto ON Canada;
Department of Community Health Sciences University of CalgaryCalgary AB Canada;
Department of Critical Care Medicine University of CalgaryCalgary AB Canada Australian and New;
Department of Medicine University of CalgaryCalgary AB Canada;
Foothills Medical Centre Multisystem Intensive Care Unit Alberta Health ServicesEdmonton AB;
Department of Medicine Queen's UniversityKingston ON Canada;
机译:丹麦肝素的成本效果与未分叉的肝素用于预防危重病人的静脉血栓栓塞
机译:竞争性风险分析,用于评价达肝素与普通肝素对外科手术重症患者静脉血栓栓塞的疗效
机译:达尔肝素评估的竞争风险分析与医学危险患者静脉血栓栓塞的无分支肝素
机译:基于WSOM的妇科肿瘤手术患者静脉血栓栓塞评估与预防的预警模型
机译:在学术医学中心对有风险或被诊断患有静脉血栓栓塞(VTE)的患者的管理进行审查;和VTE诊断策略的成本效益
机译:竞争性风险分析用于评价达肝素与普通肝素对外科手术重症患者静脉血栓栓塞的疗效
机译:Dalteparin与普通肝素预防重症患者静脉血栓栓塞的成本效益